These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 2877399

  • 21. Effects of l-stepholidine on tyrosine hydroxylase activity in rat corpus striatum.
    Guo X, Chen LJ, Buda M, Jin GZ.
    Zhongguo Yao Li Xue Bao; 1992 Jul; 13(4):289-92. PubMed ID: 1360740
    [Abstract] [Full Text] [Related]

  • 22. Biochemical and behavioral evaluation of pergolide as a dopamine agonist in the rat brain.
    Jiang DH, Reches A, Wagner HR, Fahn S.
    Neuropharmacology; 1984 Mar; 23(3):295-301. PubMed ID: 6539428
    [Abstract] [Full Text] [Related]

  • 23. Remoxipride shows low propensity to block functional striatal dopamine D2 receptors in vitro.
    Westlind-Danielsson A, Gustafsson K, Andersson I.
    Eur J Pharmacol; 1994 Dec 15; 288(1):89-95. PubMed ID: 7705472
    [Abstract] [Full Text] [Related]

  • 24. Effect of 7-(3-[4-(2,3-dimethylphenyl)piperazinyl]propoxy)- 2(1H)-quinolinone (OPC-4392), a newly synthesized agonist for presynaptic dopamine D2 receptor, on tyrosine hydroxylation in rat striatal slices.
    Kiuchi K, Hirata Y, Minami M, Nagatsu T.
    Life Sci; 1988 Dec 15; 42(3):343-9. PubMed ID: 2892110
    [Abstract] [Full Text] [Related]

  • 25. Striatal synaptosomal tyrosine hydroxylase activity. A model system for study of presynaptic dopamine receptors.
    McMillen BA.
    Biochem Pharmacol; 1982 Aug 15; 31(16):2643-7. PubMed ID: 6128002
    [Abstract] [Full Text] [Related]

  • 26. 7-[3-(4-[2,3-Dimethylphenyl]piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), a presynaptic dopamine autoreceptor agonist and postsynaptic D2 receptor antagonist.
    Yasuda Y, Kikuchi T, Suzuki S, Tsutsui M, Yamada K, Hiyama T.
    Life Sci; 1988 Aug 15; 42(20):1941-54. PubMed ID: 3130534
    [Abstract] [Full Text] [Related]

  • 27. Dopamine turnover and glutamate decarboxylase activity in the rat brain after acute and chronic treatment with raclopride, a dopamine D2-selective antagonist.
    Fowler CJ, Magnusson O, Thorell G, Mohringe B, Huang RB.
    Neuropharmacology; 1987 Apr 15; 26(4):339-45. PubMed ID: 2438585
    [Abstract] [Full Text] [Related]

  • 28. Agonist--antagonist interaction on dopamine receptors in brain, as reflected in the rates of tyrosine and tryptophan hydroxylation.
    Carlsson A, Kehr W, Lindqvist M.
    J Neural Transm; 1977 Apr 15; 40(2):99-113. PubMed ID: 323424
    [Abstract] [Full Text] [Related]

  • 29. Differential agonist profile of the enantiomers of 3-PPP at striatal dopamine autoreceptors: dependence on extracellular dopamine.
    Clark D, Salah RS, Galloway MP.
    Synapse; 1991 Jul 15; 8(3):169-76. PubMed ID: 1948667
    [Abstract] [Full Text] [Related]

  • 30. Inhibition of striatal tyrosine hydroxylase by low concentrations of apomorphine.
    Laschinski G, Kittner B, Bräutigam M.
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep 15; 327(2):114-8. PubMed ID: 6149468
    [Abstract] [Full Text] [Related]

  • 31. Attenuation by pergolide of haloperidol-induced striatal dopamine receptor density.
    Koller WC.
    J Clin Psychopharmacol; 1984 Dec 15; 4(6):343-5. PubMed ID: 6512004
    [Abstract] [Full Text] [Related]

  • 32. The dopamine D2 antagonist remoxipride acts in vivo on a subpopulation of dopamine D2 receptors.
    Ogren SO, Rosén L, Fuxe K.
    Neuroscience; 1994 Jul 15; 61(2):269-83. PubMed ID: 7969908
    [Abstract] [Full Text] [Related]

  • 33. Demonstration of autoreceptors on dopamine neurons in different brain regions of rats treated with gammabutyrolactone.
    Andén NE, Grabowska-Andén M, Liljenberg B.
    J Neural Transm; 1983 Jul 15; 58(3-4):143-52. PubMed ID: 6420514
    [Abstract] [Full Text] [Related]

  • 34. Repeated cocaine administration results in supersensitivity of striatal D-2 dopamine autoreceptors to pergolide.
    Dwoskin LP, Peris J, Yasuda RP, Philpott K, Zahniser NR.
    Life Sci; 1988 Jul 15; 42(3):255-62. PubMed ID: 3275855
    [Abstract] [Full Text] [Related]

  • 35. Evidence for a specific effect of BHT 920, an azepine derivative, on tyrosine hydroxylase in the dopaminergic system of the rat.
    Jennewein HM, Bruckwick EA, Hanbauer I, Mierau J, Lovenberg W.
    Eur J Pharmacol; 1986 Apr 29; 123(3):363-9. PubMed ID: 2873043
    [Abstract] [Full Text] [Related]

  • 36. Dopamine receptor affinities in vitro and neurochemical effects in vivo of pergolide and its metabolites.
    Wong DT, Threlkeld PG, Bymaster FP.
    Arzneimittelforschung; 1993 Apr 29; 43(4):409-12. PubMed ID: 7684223
    [Abstract] [Full Text] [Related]

  • 37. Identification and characterization of peripheral neuronal dopamine receptors in the rat.
    Dupont AG, Lefebvre RA, Bogaert MG.
    Clin Exp Hypertens A; 1987 Apr 29; 9(5-6):913-29. PubMed ID: 2887314
    [Abstract] [Full Text] [Related]

  • 38. Presynaptic dopamine autoreceptors control tyrosine hydroxylase activation in depolarized striatal dopaminergic terminals.
    el Mestikawy S, Glowinski J, Hamon M.
    J Neurochem; 1986 Jan 29; 46(1):12-22. PubMed ID: 2866232
    [Abstract] [Full Text] [Related]

  • 39. Preserved striatal tyrosine hydroxylase activity, assessed in vivo, following neonatal hypoxia-ischemia.
    Burke RE, Reches A.
    Brain Res Dev Brain Res; 1991 Aug 19; 61(2):277-80. PubMed ID: 1684313
    [Abstract] [Full Text] [Related]

  • 40. Stimulation of tyrosine hydroxylase activity by cyclic AMP in synaptosomes and in soluble striatal enzyme preparations.
    Goldstein M, Bronaugh RL, Ebstein B, Roberge C.
    Brain Res; 1976 Jun 18; 109(3):563-74. PubMed ID: 6124
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.